A new species of pangolin has been discovered, but already it is deemed to be threatened by illegal trade. The Indo-Burmese pangolin (Manis indoburmanica ) is the tenth to be found and was identified by scientists who were conducting routine examination of pangolin scales seized in India. Some of these scales were identified as coming from […]
The Government of China has made a commitment (Chinese) to supporting the development of substitutes for endangered wildlife used in traditional Chinese medicine (TCM). The announcement by the National Medical Products Administration of China (NMPA) is an encouraging step towards ending the use of threatened wildlife in TCM and represents tangible progress following a proposal […]
Norges Bank has divested from a major traditional Chinese medicine (TCM) company in the wake of EIA’s major exposé Investing in Extinction, which found the body parts of threatened leopards and pangolins being used as ingredients in at least 88 products. The bank cited an ‘unacceptable risk’ of Tianjin Pharmaceutical Da Re Tang Group Corp […]
EIA sent teams of campaigners from our UK and US offices to the 77th meeting of the Standing Committee (SC77) of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES)
Illegal wildlife trade is happening on a large scale to supply the parts and products of protected species such as leopards, pangolins, rhinos and tigers to serve as ingredients in some traditional Chinese medicines – and some big international household names are invested
A new EIA UK investigation has found the body parts of threatened leopards and pangolins being used as ingredients in at least 88 traditional Chinese medicine (TCM) products Manufactured by 72 Chinese companies and licensed by the National Medical Products Administration of China, some of those identified also contain tiger and rhino, in contravention of […]